Literature DB >> 31202642

Bovine respiratory disease (BRD) cause-specific and overall mortality in preweaned calves on California dairies: The BRD 10K study.

S A Dubrovsky1, A L Van Eenennaam1, B M Karle2, P V Rossitto3, T W Lehenbauer4, S S Aly5.   

Abstract

Mortality in preweaned dairy calves is a significant source of economic loss for dairy producers. In particular, bovine respiratory disease (BRD) is a leading cause of death in preweaned dairy calves. The objectives of this study were to investigate management practices and their effects on mortality, both that specifically attributed to BRD and overall mortality due to all causes, in preweaned dairy calves. Rates of failure of passive transfer of immunity (FPT) are also reported. The study consisted of a convenience sample of 5 dairies across California, selected based on management practices, calf records, location, and size. Trained study personnel performed comprehensive calf management surveys on every dairy at least once every season. Calves were enrolled in the study at birth and followed until weaning. Mixed-effect logistic regression models were specified for the outcomes all-cause mortality (any death before weaning) and mortality attributed to BRD. The 2 final models included a total of 11,470 calves that were born on the study dairies and followed until weaning. The study cohort's overall crude mortality was 2.8%, with crude mortality of individual dairies ranging from 1.7 to 7.2%. The proportion of mortality attributed to BRD was 19.3%, with a range of 0 to 27.1% on the study dairies. Increasing the frequency of changing maternity pen bedding was associated with a decreased risk of mortality due to BRD. Calves diagnosed with BRD in the spring had an increased risk of mortality compared with calves born in the summer; mortality in calves with fall and winter BRD diagnoses did not different significantly from that in summer. Season of mortality was not significant in either model. Feeding ≥5.7 L of milk per day per calf (vs. ≤3.7 L/d) decreased the risk of mortality in calves over 21 d of age. Twins had a 68% increased risk of all-cause mortality compared with calves born as singletons. Both mortality models showed an association between administration of a modified live vaccine in dams (targeting BRD pathogens) and a decreased risk of mortality in calves. Using a serum total protein cut-off of 5.2 g/dL, 16.8% of calves had FPT, with a mean serum total protein concentration of 5.94 ± 0.06 g/dL across all calves sampled.
Copyright © 2019 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bovine respiratory disease; epidemiology; mortality

Mesh:

Year:  2019        PMID: 31202642     DOI: 10.3168/jds.2018-15463

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  13 in total

1.  Social networks respond to a disease challenge in calves.

Authors:  Katharine C Burke; Sarah do Nascimento-Emond; Catherine L Hixson; Emily K Miller-Cushon
Journal:  Sci Rep       Date:  2022-06-01       Impact factor: 4.996

2.  Genetic and non-genetic factors associated with health and vitality traits in beef calves.

Authors:  Tom Condon; Craig Murphy; Roy D Sleator; Michelle M Judge; Siobhan Ring; Donagh P Berry
Journal:  J Anim Sci       Date:  2021-07-01       Impact factor: 3.159

3.  Portable Electronic Nose for Analyzing the Smell of Nasal Secretions in Calves: Toward Noninvasive Diagnosis of Infectious Bronchopneumonia.

Authors:  Tatiana Kuchmenko; Anastasiia Shuba; Ruslan Umarkhanov; Anton Chernitskiy
Journal:  Vet Sci       Date:  2021-04-27

4.  Non-specific protection from respiratory tract infections in cattle generated by intranasal administration of an innate immune stimulant.

Authors:  William Wheat; Lyndah Chow; Vanessa Rozo; Julia Herman; Kelly Still Brooks; Aimee Colbath; Randy Hunter; Steven Dow
Journal:  PLoS One       Date:  2020-06-25       Impact factor: 3.240

Review 5.  Bovine Respiratory Disease Vaccination Against Viral Pathogens: Modified-Live Versus Inactivated Antigen Vaccines, Intranasal Versus Parenteral, What Is the Evidence?

Authors:  Manuel F Chamorro; Roberto A Palomares
Journal:  Vet Clin North Am Food Anim Pract       Date:  2020-07       Impact factor: 3.357

6.  Prevalence and Molecular Characterization of Mycoplasma Species, Pasteurella multocida, and Staphylococcus aureus Isolated from Calves with Respiratory Manifestations.

Authors:  Youserya M Hashem; Walid S Mousa; Eman E Abdeen; Hanaa M Abdelkhalek; Mohammed Nooruzzaman; Ahmad El-Askary; Khadiga A Ismail; Ayman M Megahed; Ahmed Abdeen; Enas A Soliman; Gamal Wareth
Journal:  Animals (Basel)       Date:  2022-01-27       Impact factor: 2.752

7.  Effectiveness of two intranasal vaccines for the control of bovine respiratory disease in newborn beef calves: A randomized non-inferiority multicentre field trial.

Authors:  N Masset; F Meurens; M Marie; P Lesage; A Lehébel; N Brisseau; S Assié
Journal:  Vet J       Date:  2020-08-19       Impact factor: 2.688

8.  2018 Survey of antimicrobial drug use and stewardship practices in adult cows on California dairies: post-Senate Bill 27.

Authors:  Pius S Ekong; Essam M Abdelfattah; Emmanuel Okello; Deniece R Williams; Terry W Lehenbauer; Betsy M Karle; Joan D Rowe; Edith S Marshall; Sharif S Aly
Journal:  PeerJ       Date:  2021-07-13       Impact factor: 2.984

9.  Antimicrobial Resistance in Isolates from Cattle with Bovine Respiratory Disease in Bavaria, Germany.

Authors:  Alexander Melchner; Sarah van de Berg; Nelly Scuda; Andrea Feuerstein; Matthias Hanczaruk; Magdalena Schumacher; Reinhard K Straubinger; Durdica Marosevic; Julia M Riehm
Journal:  Antibiotics (Basel)       Date:  2021-12-15

10.  2018 Survey of factors associated with antimicrobial drug use and stewardship practices in adult cows on conventional California dairies: immediate post-Senate Bill 27 impact.

Authors:  Pius S Ekong; Essam M Abdelfattah; Emmanuel Okello; Deniece R Williams; Terry W Lehenbauer; Betsy M Karle; Joan D Rowe; Sharif S Aly
Journal:  PeerJ       Date:  2021-07-13       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.